GlassScriptPhysician profile
Razi M Arifuddin
NPI 1124085410
$1,362.43
in general payments reported to CMS, 2019-2025
13 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $170 · 2021: $74.69 · 2022: $54.25 · 2023: $47.04 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $605.96 | 2019 | |
| Olympus America INC. | $314.41 | 2022-2025 | Single Use Repositionable Clip, Visiglide, Endoclot Phs |
| Abbvie INC. | $141.96 | 2019-2021 | |
| Gilead Sciences, INC. | $50.21 | 2019-2020 | |
| Pfizer INC. | $45.96 | 2019 | |
| Janssen Biotech, INC. | $43.99 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.84 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $25.53 | 2021 | |
| Merck Sharp & Dohme LLC | $18.76 | 2019 | |
| Qol Medical, LLC | $18.65 | 2019 | |
| Intercept Pharmaceuticals, INC. | $18.37 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.37 | 2019 | |
| Ironwood Pharmaceuticals, INC | $17.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Razi Arifuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.